fda approval for tirzepatide Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA- approved children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ Beware ‼️ please use FDA
Description
Heart disease remains a critical issue in men and women with diabetes.
CONTENT: PRESENTATION SIZE: 1 vial in a box

Truveta Research shares a new study that explores GLP-1 reinitiation trends and factors following discontinuation.
Burping or flatulence

Early experience

Discover trending treatments transforming skincare in 2025.
